Premium
Refractory human papillomavirus‐associated oral warts treated topically with 1–3% cidofovir solutions in human immunodeficiency virus type 1‐infected patients
Author(s) -
Husak R.,
Zouboulis C.C.,
SanderBähr C.,
Hummel M.,
Orfanos C.E.
Publication year - 2005
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.2005.06461.x
Subject(s) - cidofovir , pharmacy , medicine , human papillomavirus , dermatology , human immunodeficiency virus (hiv) , family medicine , virology , virus